Expertise in
25
conditions

Dr. Fahed G. Bitar

Cardiology
552 W Foothill Blvd, 
Glendora, CA 
Accepting New Patients
Offers Telehealth
Referral may be required
Before you request
Expertise in
25
conditions
552 W Foothill Blvd, 
Glendora, CA 

Overview

Fahed Bitar is a Cardiologist practicing medicine in Glendora, California.

Dr. Bitar is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Apoplexy, Aortic Valve Stenosis, Mitral Valve Regurgitation, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Dr. Bitar is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, participating in 5 clinical trials. Dr. Bitar is currently accepting new patients.

Specialties

Cardiology

Licenses

Internal Medicine in CA

Board Certifications

American Board Of Internal Medicine

Fellowships

St. Elizabeth's Hospital of Boston , 2009 - 2010

Hospital Affiliations

Emanate Health Foothill Presbyterian Hospital
Emanate Health Inter-Community Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Community Health Group
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Nippon Life
  • INSURANCE PLAN
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 16 Less Insurance Carriers -

Locations

Foothill Cardiology
552 W Foothill Blvd, Glendora, CA 91741
Other Locations
Foothill Cardiology
315 N 3rd Ave, Covina, CA 91723

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
A Randomized Double-blind, Placebo-controlled, Multicenter Trial Assessing the Impact of Lipoprotein (a) Lowering With Pelacarsen (TQJ230) on Major Cardiovascular Events in Patients With Established Cardiovascular Disease
Enrollment Status: Completed
Publish Date: August 28, 2026
Intervention Type: Drug
Study Drug: TQJ230
Study Phase: Phase 3
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
The Effect of Tirzepatide Versus Dulaglutide on Major Adverse Cardiovascular Events in Patients With Type 2 Diabetes (SURPASS-CVOT)
Enrollment Status: Completed
Publish Date: July 08, 2026
Intervention Type: Drug
Study Drugs: Tirzepatide, Dulaglutide
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
A Randomized, Double-Blind, Placebo- Controlled Study to Investigate the Efficacy and Safety of Injectafer® (Ferric Carboxymaltose) as Treatment for Heart Failure With Iron Deficiency /and Sub-Study
Enrollment Status: Completed
Publish Date: July 03, 2024
Intervention Type: Drug
Study Drug: Ferric Carboxymaltose
Study Phase: Phase 3
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Efficacy and Safety of LY3298176 Once Weekly Versus Insulin Glargine in Patients With Type 2 Diabetes and Increased Cardiovascular Risk (SURPASS-4)
Enrollment Status: Completed
Publish Date: February 14, 2022
Intervention Type: Drug
Study Drugs: Tirzepatide, Insulin Glargine
Study Phase: Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
24
conditions
Expertise in
24
conditions
Referral may be required
Before you request

Los Angeles Biomedical Research Institute At Harbor-UCLA Medical Cente

1124 W Carson St, 
Torrance, CA 
 (32.0 miles away)
310-222-2515
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Matthew Budoff is a Cardiologist practicing medicine in Torrance, California. Dr. Budoff is highly rated in 24 conditions, according to our data. His clinical expertise encompasses Coronary Heart Disease, Atherosclerosis, Heart Attack, Hormone Replacement Therapy (HRT), and Heart Bypass Surgery. Dr. Budoff is currently accepting new patients.

Expertise in
39
conditions
Expertise in
39
conditions
Referral may be required
Before you request

Office

100 Medical Plz E Ste 630, 
Los Angeles, CA 
 (32.9 miles away)
310-825-8816
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Gregg Fonarow is a Cardiologist practicing medicine in Los Angeles, California. Dr. Fonarow is highly rated in 39 conditions, according to our data. His clinical expertise encompasses Heart Failure, Heart Attack, Atrial Fibrillation, Percutaneous Coronary Intervention (PCI), and Thrombectomy. Dr. Fonarow is currently accepting new patients.

Expertise in
36
conditions
Expertise in
36
conditions
Referral may be required
Before you request

Cedars-Sinai Electrophysiology Program

127 S San Vicente Blvd Ste A3600, 
Los Angeles,, CA 
 (28.8 miles away)
310-423-3851
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Robert Siegel is a Cardiologist practicing medicine in Los Angeles,, California. Dr. Siegel is highly rated in 36 conditions, according to our data. His clinical expertise encompasses Mitral Valve Regurgitation, Aortic Regurgitation, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR). Dr. Siegel is currently accepting new patients.

Frequently Asked Questions about Dr. Fahed G. Bitar

How do I make an appointment with Dr. Fahed G. Bitar?

You can book an appointment with Dr. Fahed G. Bitar by calling their office at 626-915-4700. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Fahed G. Bitar a top-rated expert for Apoplexy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Fahed G. Bitar is classified as an Distinguished expert for Apoplexy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Fahed G. Bitar specialize in?

While Dr. Fahed G. Bitar is a Cardiology, they have specific expertise in Apoplexy, Aortic Valve Stenosis, and Mitral Valve Regurgitation. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.

Does Dr. Fahed G. Bitar accept my insurance?

Dr. Fahed G. Bitar accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 626-915-4700 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Bitar's expertise for a condition
ConditionClose
    View All 24 Advanced Conditions
    View All 45 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile